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Evidence from international observational studies and one randomized 
controlled trial found no survival benefit of "early start "of dialysis, 
generally defined as predialysis eGFR >10 ml/min/1.73m2 (ES)(1). We 
compared the frequency of ES as reported to dialysis registries for the US, 
Canada, France, Australia and the UK between   2005- 2015. In 2015, ES 
was more common in the US, Canada and France (38.8%, 37.2%, 31.8%, 
respectively) than Australia and the UK (21.7% and 19.1% respectively), It  
has been suggested that early start rates may be influenced by financial 
incentives, but this alone does not explain these differences (2,3).  
 For dialysis patients aged >75 ES was approximately half as frequent in the 
UK and Australia versus the US and Canada and France and appears to have 
plateaued for most countries by 2010 (figure1). Predialysis eGFR >15 
ml/min/1.73m2 for >75 new dialysis starts with comorbidity congestive heart 
failure in the US, Canada and France was 17.0%, 17.6% and 18.0%, 
respectively, a finding that deserves further exploration.  
 The first eGFR related dialysis initiation guidelines appeared in the 
US in 1997(1). These guidelines might have had the greatest impact on ES 
in the US. For African Americans ES in 2015 was 26.7% versus 39.4% for 
whites. Thus, the US may have the highest rate of early start after controlling 
for race. Since ES has not been shown to provide a comorbidity adjusted 
survival or quality of life benefit one could argue that all five countries 
should find ways to decrease the rates of ES. This may be especially 
important for the 75+ populations where conservative management may be 
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Figure 1 legend: 
 
Proportion of the population aged > 75 years initiating dialysis “early”, 
defined by starting eGFR > 10 ml/min/1.73m2 shown in two categories: 
eGFR 10 - 14.9; and eGFR > 15 ml/min/1.73m2  in 2005, 2010 and 2015 
across five countries. The incident average dialysis >75 aged population 
during this time period was 28,214 for the US, 1,330 for Canada, 3,310 for 
France, 492 for Australia, and 1,652 for U.K. Missing starting eGFR 
measurements were removed from all calculations and measured on average 
between 2005-2015-- 2.9% in the US, 9.3% in Canada, 17.8% in France, 
1.9% in Australia, and 51.8% in the U.K.  France used data from as many 
regions as were available for each study period.  
 
